Concord Biotech Schedules Q2FY27 Earnings Conference Call for 28th Oct'26
Concord Biotech Ltd 路 Intimation 路 28 Oct 2026, 3:30 pm
Concord Biotech Schedules Q2FY27 Earnings Conference Call for 28th Oct'26 Concord Biotech Limited will host an earnings conference call on 28th Oct'26 at 3:30 PM IST to discuss its unaudited standalone and consolidated financial and operational performance for Q2FY27 and the half-year ended 30th Sep'26. The call will be hosted by Choice Institutional Equities and attended by key management, including Chairman & MD Sudhir Vaid, Joint MD & CEO Ankur Vaid, and CFO Raviraj Karia. Primary access numbers include +91 22 6280 1395 and +91 22 7115 8112.
Original exchange filing (PDF)
More announcements from Concord Biotech Ltd
- Intimation of allotment of Bonus equity Shares 路 05 Nov 2026
- Transcript of Q2 - FY27 Earnings call held on October 28, 2026 路 03 Nov 2026
- Earning Call Recording- For the Second Quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 03rd and 4th November, 2026. 路 28 Oct 2026
- Investor''s presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30, 2026 路 28 Oct 2026
- The Board of Directors at its meeting held on October 27, 2026 has fixed Wednesday, November 04, 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1. 路 28 Oct 2026
- Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026. 路 28 Oct 2026
- Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
